echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Israeli study finds that Pfizer's new crown vaccine may be associated with myocarditis

    Israeli study finds that Pfizer's new crown vaccine may be associated with myocarditis

    • Last Update: 2021-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 2, the Israeli Ministry of Health stated that the few cases of heart inflammation observed by some young men in the country after the second dose of Pfizer/BioNTech's new crown vaccine could be related to the Pfizer vaccine.


    The few cases of heart inflammation observed by some young men in the country after the second dose of Pfizer/BioNTech's new crown vaccine can be related to Pfizer vaccine.


    In Israel, between December 2020 and May 2021, 275 cases of myocarditis were reported, of which more than 5 million people were vaccinated.


    Some health experts recommend giving young people only one injection to avoid the side effects of the second dose.


    In response, Pfizer said in a statement that Pfizer said it did not observe a higher incidence of myocarditis than the general population would normally expect.


    Considering that myocarditis is usually caused by a viral infection , there is currently no indication that the above cases are causally related to vaccination, and the benefits of vaccination still outweigh the risks.


    The Vaccine Safety Team of the Centers for Disease Control and Prevention is also investigating "relatively few" reports of the condition of young Americans who have been vaccinated.


    Currently about 55% of the Israeli population has been vaccinated.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.